Dementia Treatment Articles & Analysis
5 news found
The trial sponsor is INmune Bio, a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that harness the patient’s innate immune system to fight disease. ...
Private investors can now invest in a company aiming to disrupt and transform a $1.3 trillion dementia market alone while benefiting millions living with neurodegenerative diseases. Diseases like Dementia and Alzheimer’s afflict millions of people across the globe, while over 1 billion people worldwide – 1 in 6 – suffer from a neurological ...
The Company also announced the first patient in its ROCKIT-1 (ROCK Inhibitor in Tauopathies – 1) trial of BRAVYL in Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS) patients has commenced treatment. ABOUT WANDERING IN DEMENTIA PATIENTS Dementia is the leading cause of dependency and disability amongst older adults. ...
Alzheimer Centrum Amsterdam is the diagnosis and treatment center for dementia, with a focus on dementia at a young age. Our mission is to make dementia negotiable, treatable and eventually heal. Amsterdam UMC At Amsterdam UMC, more than 15,000 professionals strive to provide good and accessible care. ...
We are SO EXCITED to support the first Charity Gala for Hope for Dementia that will take place on January 31, 2019 in Montreal, QC! Join us for an unforgettable evening of Live Entertainment, Dignitary Speeches from Local & Community Leaders and Touching Story-Telling to support Hope for Dementia! Hope for Dementia is a non-profit ...